Business The Tata Trusts saga explained A story about the rift at Tata Trusts where legacy, leadership, and power are all being tested.
Sunny Side Up š³Quake resistant real estate, Xania Monet and more... A Sunny Side Up edition where we talk about earthquake resistant buildings being the future of real estate, AI music artists and more.
Weekly Pine Labs IPO, SEBIās T+0 delay, quantum computing and moreā¦ Mutual fund costs, the Groww IPO, Bankim Brahmbhatt and more in this week's wrapup.
Capital Markets What happened to all the T+0 excitement? An explainer on why SEBI has indefinitely extended the deadline for stockbrokers to be fully ready for T+0 settlements.
Business A breakthrough that might break the internet An explainer on Googleās latest breakthrough with its quantum computing chip named Willow, and how it might affect you and me.
Business Bankim Brahmbhatt and the $500 million lesson in lending against thin air An explainer on how a recently acquired firm under BlackRock got scammed out of half a billion dollars.
Capital Markets Why mutual funds will soon cost less An explainer that dives into the SEBI consultation paper on mutual funds asset management charges.
Sunny Side Up š³3I/ATLAS, 67 and more... A Sunny Side Up edition where we talk about what 3I/ATLAS is, 67, and more...
Weekly FDI in public sector banks, the Lenskart IPO pitch, loans against silver and moreā¦ RBL's foreign deal, mutual funds and pre-IPO deals, Orkla IPO and more in this week's wrapup.
Policy What you need to know about loans against silver An explainer on the recent buzz about the RBI formalising silver backed loans.
Capital Markets SEBI wants mutual funds to stop chasing pre-IPO deals Can mutual funds no longer access the pre-IPO market?
Business RBLās ticket to the big leagues Why is Dubaiās Emirates NBD placing a $3 billion bet on RBL Bank?
Sunny Side Up Lab diamond conspiracy, happy elephants & more... A Sunny Side Up edition where we talk about a dramatic twist in lab-grown diamond prices, how to save elephants, and more.
Weekly RBIās report on SME IPOs, IEX info leaks, Indiaās China drug dependence and moreā¦ Reliability of IMF forecasts, new EPFO withdrawal rules, and more in this week's wrapup.
Macro How reliant is the Indian pharma industry on China? A story about why the worldās pharmacy still needs Chinaās chemistry and what India can do to catch up.
Policy Whatās up with the new EPFO rules? An explainer about the newly proposed Employees' Provident Fund Organisation rules.
Economy Can India really grow at 6.6% like the IMF says? A story that explores how accurate the IMFās growth projections for India really are.
Capital Markets The CERC-IEX insider trading saga explained Inside SEBIās interim order that exposed insider trading in IEX shares, linked to Indiaās power regulator, CERC.
Sunny Side Up š³Trash tournaments, self-healing tyres, and more... A Sunny Side Up edition where we talk about Spogomi, a tyre that heals punctures by itself and more.
Weekly Index and chill?, the fall of Bira 91, and moreā¦ Why RBI is rewriting its liquidity rules, winning theories behind 2025 Nobel in Economics, and more in this week's wrapup.
Business Why is everyone talking about the fall of Bira 91? An explainer on the financial troubles brewing at Bira 91 and whether it can reclaim its glory days.
